Human Papillomavirus Infection clinical trials
42 active trials name this condition. Describe your situation to see which ones you may be eligible for.
Refine by biomarker
By location
- Assessing Administration of pBI-11 Via Electroporation for the Treatment of Patients With HPV16/18+
- A Study of the Preliminary Efficacy of DARE-HPV to Treat High-risk Persistent Human Papillomavirus (hrHPV)
- Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)
- Empowering Vietnamese Americans
- Playing Game to Learn About Children's Vaccine Project
- Self-collection for HPV Testing to Improve Cervical Cancer Prevention (SHIP) Trial (LMI-001-A-S04)
- Investigating Facilitator-driven, Multi-level Implementation Strategies in Federally Qualified Health Centers to Improve Provider Recommendation and HPV Vaccination Rates Among Latino/a Adolescents
- Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)
- HPV Ends Here: Increasing Uptake of the HPV Vaccine
- Educate and Improve Underserved Populations' Uptake and Completion of the HPV Vaccine
- ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
- Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
- "Facts Tell… and With Stories Sell?" Combining Viewer-tailored Personal Human Papillomavirus (HPV) Narrative Video With HPV Vaccine Information Video to Improve HPV Vaccine Uptake
- Evaluating Gardasil HPV Vaccine Humoral and Cellular Immune Responses in People With and Without HIV
- Reducing Urban Cervical Cancer Disparities
- Unidos Contra el VPH
- Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
- Rice Technologies for Cervical Cancer Screening and Diagnosis
- Prevention of Cervical Cancer Using the Genotyping Screening and Same-day Self-sampling
- Evaluation of a Novel Point-of-Care Diagnostic Test for Human Papillomavirus (HPV)
- Natural History, Epidemiology and Pathogenesis of Severe HPV-Related Diseases (Neptune)
- Feasibility of HPV Testing With Mail-delivered Sample Collection Kits
- Natural History Study of GATA2 Deficiency and Related Disorders
- Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer
- PopSci CHW4CervixHealth
- HPV Vaccine Reduced Dose
- Culturally Targeted Health Communication and Receptivity to the Human Papillomavirus Vaccine Among Parents in Flint, MI
- PCOM2 - The Physician Communication Intervention, Version 2.0
- Provider Recommendation and HPV Vaccination
- Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
- Use of ACU-D1 in HPV Associated Vulvar and Perianal Lesions in People With HIV
- Testing for Safety and Immune Effects of PDS0101, an Anti-HPV Therapy, Among People Living With HIV
- Developing and Implementing HPV SCREENED
- HPV Detection Using Self-Collected Menstrual Blood
- C-3002: Enhancing Cervical Cancer Screening Access and Follow-up Care at 'CASCADE' Clinical Sites in the United States
- Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial
- Multilevel Peer-to-Peer HPV Vaccination and Wellness Educational Program in School Based Health Centers
- Clinical Trial Assessing the Safety and Immunologic Correlates of Heterologous Prime-Boost With pNGVL4a-Sig/E7(Detox)/HSP70 and TA-HPV in Healthy Donors Followed by Peripheral Blood Collection
- Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies
- Accelerating the Implementation of a Breast and Cervical Cancer Screening and HPV Vaccination Intervention
- Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
- Feasibility Trial of a Multi-level Media Production and Social Marketing Campaign to Reduce HPV Vaccine Hesitancy
Guides for people searching for a trial
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.
Showing active trials that list “Human Papillomavirus Infection” as a condition. Eligibility shown on each trial is an estimate — the trial's study team makes the final decision.